RWD161 Therapeutic Drug Monitoring (TDM) of Infliximab Is Associated with Lower Biologic Switch & Expenditures Compared to No-TDM Cohort of IBD Patients Based on 12 to 48-Month Real-World Outcomes from a US Community GI Practice

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Value in Health

Topics

Medicine

Epidemiology

Immunology

Internal Medicine

Pediatrics, Perinatology And Child Health

Show all topics

DOI

10.1016/j.jval.2024.03.1815